SEC investigating Illumina over acquisition of cancer test developer Grail

by | Aug 11, 2023 | Consumer Products, FEATURED, HEADLINE, Investing, Stocks

The U.S. Securities and Exchange Commission is investigating Illumina over its controversial $7.1 billion acquisition of cancer test developer Grail, …

FEATURED